Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel melatonin-based treatments for major depression.
Serfaty M, Raven PW. Serfaty M, et al. Lancet. 2012 Jan 21;379(9812):217; author reply 217-9. doi: 10.1016/S0140-6736(12)60098-1. Lancet. 2012. PMID: 22265626 No abstract available.
Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M, Cape J, Serfaty M, Shafran R, Kabir T, Tyrer P, Clarke CS, Nazareth I. Buszewicz M, et al. Health Technol Assess. 2017 Aug;21(45):1-138. doi: 10.3310/hta21450. Health Technol Assess. 2017. PMID: 28853392 Free PMC article. Clinical Trial.
The clinical and cost-effectiveness of a Victim Improvement Package (VIP) for the reduction of chronic symptoms of depression or anxiety in older victims of common crime (the VIP trial): study protocol for a randomised controlled trial.
Serfaty M, Aspden T, Satchell J, Kessel A, Laycock G, Brewin CR, Buszewicz M, O'Keeffe A, Hunter R, Leavey G, Cuming-Higgs J, Drennan V, Riveros M, Andrew D, Blanchard M. Serfaty M, et al. Trials. 2020 Apr 16;21(1):333. doi: 10.1186/s13063-020-4211-9. Trials. 2020. PMID: 32299478 Free PMC article.
Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.
Schrag A, Carroll C, Duncan G, Molloy S, Grover L, Hunter R, Brown R, Freemantle N, Whipps J, Serfaty MA, Lewis G. Schrag A, et al. Among authors: serfaty ma. BMC Neurol. 2022 Dec 12;22(1):474. doi: 10.1186/s12883-022-02988-5. BMC Neurol. 2022. PMID: 36510237 Free PMC article.
47 results